Skip Nav Destination
Issues
August 2008
ISSN 0009-3157
EISSN 1421-9794
Journal Name Change
Vol. 1-12 (1960-1967) were published under the journal's former title Chemotherapia.
Chemotherapy 2008, Vol. 54, No. 4
Microbiology
Modes of Action of the New Arylguanidine Abafungin beyond Interference with Ergosterol Biosynthesis and in vitro Activity against Medically Important Fungi
C. Borelli; M. Schaller; M. Niewerth; K. Nocker; B. Baasner; D. Berg; R. Tiemann; K. Tietjen; B. Fugmann; S. Lang-Fugmann; H.C. Korting
Chemotherapy (2008) 54 (4): 245–259.
https://doi.org/10.1159/000142334
Review
Optimization of Antibiotic Use in Hospitals – Antimicrobial Stewardship and the EU Project ABS International
Chemotherapy (2008) 54 (4): 260–267.
https://doi.org/10.1159/000149716
Clinical Study
Microbiology
Quinolone Resistance and Correlation to Other Antimicrobial Resistances in Faecal Isolates of Escherichia coli in Hong Kong
Yiu Wai Chu; Terence K.M. Cheung; Chi Ho Wong; Grand K.L. Tsang; Kenwai Lee; Stephen S.Y. Lau; Kai Man Kam
Chemotherapy (2008) 54 (4): 274–278.
https://doi.org/10.1159/000149718
Pharmacology
Clinical Study
Ciprofloxacin-Induced Urticaria and Tenosynovitis: A Case Report
Chemotherapy (2008) 54 (4): 288–290.
https://doi.org/10.1159/000149720
Experimental Chemotherapy
Clinical Study
Efficacy of Gemcitabine for Locally Advanced Pancreatic Cancer: Comparison with 5-Fluorouracil-Based Chemoradiotherapy
Minoru Tada; Masatoshi Arizumi; Yousuke Nakai; Takashi Sasaki; Hirofumi Kogure; Osamu Togawa; Saburo Matsubara; Takeshi Tsujino; Kenji Hirano; Naoki Sasahira; Hiroyuki Isayama; Takao Kawabe; Masao Omata
Chemotherapy (2008) 54 (4): 302–308.
https://doi.org/10.1159/000151226
Experimental Chemotherapy
Nine Months to Progression Using Fourth-Line Liposomally Encapsulated Paclitaxel against Hepatocellular Carcinoma
Maximilian Christopeit; Georg Lenz; Roswitha Forstpointner; Kerstin Bartelheim; Robert Kühnbach; Kurt Naujoks; Andreas Schalhorn
Chemotherapy (2008) 54 (4): 309–314.
https://doi.org/10.1159/000151352
Clinical Study
Phase II Trial of Neoadjuvant Cisplatin, 5-Fluorouracil and Interferon-Alpha in Operable Squamous Cell Carcinoma of the Esophagus
Shouki Bazarbashi; Mahmoud Abdelsalam; Tarek Amin; Mazen El-Bassiouni; Hussein Soudy; Amr Elweshi; Hamed Alhusseiny; Khaled Rehman; Muhammed Memon; Dahish Ajarim
Chemotherapy (2008) 54 (4): 315–322.
https://doi.org/10.1159/000151353
Microbiology
Fluoroquinolone Resistance in Clinical Isolates of Klebsiella oxytoca
Chemotherapy (2008) 54 (4): 323–327.
https://doi.org/10.1159/000151266
Enhancement of the Antibiotic Activity against a Multiresistant Escherichia coli by Mentha arvensis L. and Chlorpromazine
Henrique D.M. Coutinho; José G.M. Costa; Edeltrudes O. Lima; Vivyanne S. Falcão-Silva; José P. Siqueira-Júnior
Chemotherapy (2008) 54 (4): 328–330.
https://doi.org/10.1159/000151267